Abstract:Objective To explore the preventive effect of neostigmine on postoperative delirium and prognosis in elderly patients. Methods A prospective study enrolled 232 elderly patients who underwent elective surgery under general anesthesia at the First People′s Hospital of Lianyungang City from January to July 2024. Using a random number table method, the patients were divided into a neostigmine group and a placebo group, with 116 in each group. After the surgery, when the train-of-four stimulation (TOF) counts were ≥ 2, the neostigmine group was given 0.04mg/kg neostigmine intravenously, while the placebo group was given an equal amount of normal saline intravenously. Preoperative physical indicators, perioperative vital signs, tracheal extubation time, dosage of atropine and other medications, as well as postoperative indicators such as delirium incidence on days 1-3 after surgery, post-anesthesia care unit (PACU) stay time after anesthesia, and postoperative adverse reactions. SPSS 21.0 was used for data analysis. Multiple logistic regression analysis was used to investigate the effects of neostigmine and atropine on the incidence of postoperative delirium. ResultsThe extubation time [(9.6±12.8) vs (13.7±3.8) min], PACU stay time [(26.7±1.8) vs (27.6±1.8) min], and hospitalization time [(12.00±3.96) vs (13.87±4.51) d] in the neostigmine group were significantly shorter than those in the placebo group, the atropine dosage [0.5 (0.3,0.5) vs 0.0 (0.0,0.3) mg] in the neostigmine group was significantly higher than that in the placebo group, and the differences were statistically significant (P<0.05 for all). The incidence of delirium within 3 days after surgery (6.9% vs 15.5%) and postoperative pulmonary complications (4.3% vs 12.1%) in the neostigmine group were significantly lower than those in the placebo group, and the differences were statistically significant (P<0.05 for both). Multivariate logistic regression analysis showed that neostigmine was an independent protective factor for postoperative delirium (OR=0.387,95%CI 0.158-0.945). Conclusion Neostigmine can effectively reduce the incidence of postoperative delirium in elderly patients and the risk of postoperative pulmonary dysfunction.